Belvedere Trading
ROIV icon

Belvedere Trading’s Roivant Sciences ROIV Stock Holding History

Belvedere Trading’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-55,600
Closed -$266K – 1197
2022
Q3 		$266K Buy
+55,600
New +$215K 0.01% 123

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Belvedere Trading's ROIV Position: Q4 2023 in Review

Belvedere Trading sold out of Roivant Sciences (ROIV) in Q4 2023, closing a stake of 5,472 shares — an estimated $63.9K sold.

Belvedere Trading first reported a position in ROIV in Q1 2023 and held it in 2 quarters. The position peaked at $63.9K in Q3 2023. 224 funds tracked by Wall St. Rank hold ROIV as of Q4 2023.

  • Belvedere Trading reported no remaining Roivant Sciences position as of Q4 2023 after selling out during the quarter.
  • Belvedere Trading sold 5,472 Roivant Sciences shares in Q4 2023, an estimated $63.9K.
  • Belvedere Trading first reported a position in Roivant Sciences in Q1 2023 and held it in 2 quarters.
  • Belvedere Trading's Roivant Sciences position peaked at $63.9K in Q3 2023.
  • 224 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2023.

Based on Belvedere Trading's 13F filing for Q4 2023, filed 13 Feb 2024.